Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Brad Tumminello
Observed names:
B. Tumminello,
Tumminello, Brad
Institutions:
The University of Texas MD Anderson Cancer Center,
Heidelberg University,
The Netherlands Cancer Institute,
Dana-Farber Cancer Institute,
University Medical Centre Mannheim,
SpringWorks Therapeutics (United States),
KU Leuven
show all 7
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Heidelberg University,
The Netherlands Cancer Institute,
Dana-Farber Cancer Institute,
University Medical Centre Mannheim,
SpringWorks Therapeutics (United States),
KU Leuven
show all 7
ORCID:
0009-0004-0967-7330
Observed ORCID:
0009-0004-0967-7330
OpenAlex ID:
A5087738653
Desmoid Tumors: A Comprehensive Review
2023
·
Meryem Bektas
, Timothy Bell
, et al.
·
Advances in Therapy
·
106
PDF
Disease and economic burden of surgery in desmoid tumors: a review
2023
·
Maria M. Fernandez
, Timothy Bell
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
14
PDF
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial
2025
·
Ravin Ratan
, Bernd Kasper
, et al.
·
Journal of Clinical Oncology
·
13
PDF
67MO Long-term nirogacestat treatment in adult patients with desmoid tumors: Updated efficacy and safety from the phase III DeFi trial
2025
·
B. Kasper
, R. Ratan
, et al.
·
ESMO Open
·
2
Table 3 from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
2026
·
Chia Jie Tan
, Connor Willis
, et al.
Table 2 from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
2026
·
Chia Jie Tan
, Connor Willis
, et al.
Table 1 from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
2026
·
Chia Jie Tan
, Connor Willis
, et al.
Supplementary Figure S2 from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
2026
·
Chia Jie Tan
, Connor Willis
, et al.
Supplementary Table S2 from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
2026
·
Chia Jie Tan
, Connor Willis
, et al.
Supplementary Figure S1 from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
2026
·
Chia Jie Tan
, Connor Willis
, et al.
Table 4 from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
2026
·
Chia Jie Tan
, Connor Willis
, et al.
Figure 1 from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
2026
·
Chia Jie Tan
, Connor Willis
, et al.
Supplementary Table S3 from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
2026
·
Chia Jie Tan
, Connor Willis
, et al.
Data from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
2026
·
Chia Jie Tan
, Connor Willis
, et al.
Supplementary Table S1 from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
2026
·
Chia Jie Tan
, Connor Willis
, et al.
Reply to: In DeFi-ance of “More Is Better”: Questioning Long-Term Nirogacestat Use in Desmoid Tumors
2026
·
Ravin Ratan
, Bernd Kasper
, et al.
·
Journal of Clinical Oncology
PDF
Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
2026
·
Chia Jie Tan
, Connor Willis
, et al.
·
Cancer Research Communications
PDF
2709P Treatment journey of nirogacestat: Timing expectations of safety and efficacy in a novel drug class
2025
·
B. Vincenzi
, C. Benson
, et al.
·
Annals of Oncology
HSD30 Characterization of Patients With Desmoid Tumors (DT) and Their Treatment Patterns Within an Academic Health System in the United States
2025
·
Chia Jie Tan
, Connor Willis
, et al.
·
Value in Health
148P The impact of desmoid tumors on patients' quality of life: Desmoid Tumor Research Foundation Natural History Study
2024
·
K.A. Mercier
, L. Hernandez
, et al.
·
ESMO Open
Tumor volume and T2 hyperintensity changes from DeFi: A phase 3, randomized, controlled trial of nirogacestat in patients with desmoid tumors.
2023
·
Thierry Alcindor
, Bernd Kasper
, et al.
·
Journal of Clinical Oncology
CO43 Burden of Surgery in Desmoid Tumors
2023
·
M. Fernandez
, T. Bell
, et al.
·
Value in Health
PDF
Abstract 5775: Survey to identify current physician preferences for the treatment of patients with desmoid tumors
2020
·
Jessica White
, Badreddin Edris
, et al.
·
Cancer Research
Show more works
View as search
Works count:
24
Citation count:
135
H-index:
3
I10-index:
3
Year
Topic
Type